Mounjaro GLP-1 Cost: What the Price Tag Really Covers

You've found a price, here's what it may not include

Picture this: you've spent twenty minutes comparing provider websites, noted a figure that looks manageable, and you're about to click through. Then you reach the checkout. Some services add a consultation fee on top of the medicine price. Others charge separately for the prescription, or for delivery, or for follow-up messages to a clinician between doses. A handful bundle aftercare into a monthly subscription that auto-renews whether or not you need the next pen.

None of that is necessarily dishonest, but it does mean the headline cost and the actual cost can end up quite different. Mounjaro pricing explained in full covers how these elements typically stack up, so you can compare like for like rather than headline against headline. For context, the wider GLP-1 tirzepatide cost picture across the private market reflects the same structure: what you pay per pen is only one number in a longer sum.

One misconception worth letting go gently: that cheaper always means equivalent. For most consumer goods that logic holds. For a prescription medicine dispensed by a pharmacy, lower cost is just as likely to reflect thinner clinical infrastructure as genuine efficiency savings. The medicine in the pen is the same; everything around it is what varies.

What shapes the Mounjaro GLP-1 cost at each stage of treatment

Tirzepatide (the active ingredient in Mounjaro) is licensed in the UK across six dose strengths, from 2.5mg up to 15mg. Treatment always begins at the lowest strength; the first pen's job is to let your body adjust, not to produce the bulk of the therapeutic effect. As your prescriber steps the dose upward over subsequent months, the per-pen cost typically rises with it.

That means the monthly figure you see advertised on a dose-specific page may not reflect what you'll pay at maintenance. It's worth understanding the full titration arc before budgeting. Our 5mg Mounjaro cost page and the 10mg cost breakdown illustrate how the numbers shift through the schedule. For a broader picture of all dose pricing, the Mounjaro cost overview is the clearest starting point.

Eli Lilly's UK list-price increase, effective 1 September 2025, pushed the highest dose from around £122 to around £330 per four-week pen at list level. Private providers pass through varying proportions of that change. As widely reported at the time, the increase was substantial and it reshaped what a realistic monthly budget looks like, especially for anyone mid-treatment at a higher dose. NICE's appraisal of tirzepatide (TA1026) and the NHS rollout criteria are separate questions, but understanding how Mounjaro works and who qualifies gives useful context before you focus on cost alone.

What nume includes, and why we're not competing on price

At nume, one price covers the consultation, the prescription, the medicine, and tracked next-working-day delivery by DPD. No subscription, no auto-renewal, no separate aftercare charge. A real prescriber (listed on the GPhC register, not a piece of software) reads every consultation the same day it is submitted. Before each repeat, your case is reviewed again from scratch. That is the service; the medicine is the vehicle for it.

We are not the cheapest option in this market, and we chose that deliberately. Competing on price for a prescription medicine would mean trimming somewhere (clinical time, delivery infrastructure, aftercare capacity) and we're not prepared to do that. What we offer instead is a fixed, transparent cost with no additions at checkout and a clinical standard our prescribers are willing to put their names to. You can read more about how we're structured on our about page, and our clinical team profile gives a sense of who is actually reviewing your consultation. If you have questions before starting, our FAQ section covers the most common ones, or you can reach the team directly.

Why cheapest is the wrong question to lead with

Cost matters. Nobody should pretend otherwise. But for a prescription-only medicine, the right first question is whether the supply chain is legitimate, and then, within legitimate options, what the price includes. The MHRA has documented large seizures of counterfeit weight-loss pens sold through informal online channels, in some cases containing insulin rather than the labelled ingredient. Sellers offering these medicines without a clinical assessment, at prices well below the private market, or via social-media messages are operating outside the law. If you want to verify any online pharmacy before you use it, the GPhC pharmacy register takes a few seconds and tells you whether a service is genuinely registered. Our own GPhC premises registration number is 9012878, and you can check it directly at any point.

Once you are satisfied a provider is legitimate, that's the moment cost comparison becomes meaningful. A small monthly saving across a twelve-month treatment course is real money. It is not, though, a reason to compromise on clinical oversight. The weight-loss treatment overview covers what responsible private treatment looks like end to end, if that broader picture is useful before you decide.